Found: 17
Select item for more details and to access through your institution.
The futility of adverse drug event reporting systems for monitoring known safety issues: A case study of myocardial infarction with rofecoxib and other drugs.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 1, p. 1, doi. 10.1002/pds.5719
- By:
- Publication type:
- Article
Estimates of hospitalization attributable to influenza and RSV in the US during 1997-2009, by age and risk status.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Modelling estimates of age-specific influenza-related hospitalisation and mortality in the United Kingdom.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prevalence and Persistence of Maternal Dengue Neutralizing Antibodies in Infants From Central and Southern Thailand: A Retrospective Cohort Study.
- Published in:
- Asia-Pacific Journal of Public Health, 2019, v. 31, n. 4, p. 288, doi. 10.1177/1010539519853396
- By:
- Publication type:
- Article
Dengue Infection in Children in Fortaleza, Brazil: A 3-Year School-Based Prospective Cohort Study.
- Published in:
- American Journal of Tropical Medicine & Hygiene, 2020, v. 103, n. 1, p. 100, doi. 10.4269/ajtmh.19-0521
- By:
- Publication type:
- Article
Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status.
- Published in:
- Influenza & Other Respiratory Viruses, 2014, v. 8, n. 5, p. 507, doi. 10.1111/irv.12258
- By:
- Publication type:
- Article
The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Model estimates of the burden of outpatient visits attributable to influenza in the United States.
- Published in:
- BMC Infectious Diseases, 2016, v. 16, p. 1, doi. 10.1186/s12879-016-1939-7
- By:
- Publication type:
- Article
Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The epidemiology of herpes zoster and its complications in Medicare cancer patients.
- Published in:
- BMC Infectious Diseases, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12879-015-0810-6
- By:
- Publication type:
- Article
Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language Processing.
- Published in:
- Drug Safety, 2024, v. 47, n. 2, p. 173, doi. 10.1007/s40264-023-01381-6
- By:
- Publication type:
- Article
Developing an Artificial Intelligence-Guided Signal Detection in the Food and Drug Administration Adverse Event Reporting System (FAERS): A Proof-of-Concept Study Using Galcanezumab and Simulated Data.
- Published in:
- Drug Safety, 2023, v. 46, n. 8, p. 743, doi. 10.1007/s40264-023-01317-0
- By:
- Publication type:
- Article
Identifying Safety Subgroups at Risk: Assessing the Agreement Between Statistical Alerting and Patient Subgroup Risk.
- Published in:
- Drug Safety, 2023, v. 46, n. 6, p. 601, doi. 10.1007/s40264-023-01306-3
- By:
- Publication type:
- Article
Correction to: Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception.
- Published in:
- Drug Safety, 2022, v. 45, n. 2, p. 155, doi. 10.1007/s40264-021-01141-4
- By:
- Publication type:
- Article
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology.
- Published in:
- Drug Safety, 2020, v. 43, n. 12, p. 1223, doi. 10.1007/s40264-020-00989-2
- By:
- Publication type:
- Article